<ARTICLE> 5 <LEGEND> THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM CONDENSED CONSOLIDATED STATEMENTS OF OXIGENE, INC. FOR THE NINE MONTHS ENDED SEPTEMBER 30 AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS. </LEGEND> <MULTIPLIER> 1000 <PERIOD-TYPE> 9-MOS <FISCAL-YEAR-END> DEC-31-1996 <PERIOD-END> SEP-30-1996 <CASH> 12427 <SECURITIES> 0 <RECEIVABLES> 0 <ALLOWANCES> 0 <INVENTORY> 0 <CURRENT-ASSETS> 12427 <PP&E> 103 <DEPRECIATION> (37) <TOTAL-ASSETS> 12803 <CURRENT-LIABILITIES> 505 <BONDS> 0 <PREFERRED-MANDATORY> 0 <PREFERRED> 0 <COMMON> 76 <OTHER-SE> 12222 <TOTAL-LIABILITY-AND-EQUITY> 12803 <SALES> 0 <TOTAL-REVENUES> 371 <CGS> 0 <TOTAL-COSTS> 0 <OTHER-EXPENSES> 4980 <LOSS-PROVISION> 0 <INTEREST-EXPENSE> 0 <INCOME-PRETAX> (4609) <INCOME-TAX> 0 <INCOME-CONTINUING> (4609) <DISCONTINUED> 0 <EXTRAORDINARY> 0 <CHANGES> 0 <NET-INCOME> (4609) <EPS-PRIMARY> (0.65) <EPS-DILUTED> (0.65)